Something seems off, FTC investigates Hims & Hers Health (NYSE: HIMS)

Federal Trade Commission has been investigating the telehealth company’s business practices for more than a year.

The probe is examining whether Hims & Hers has made it too difficult for customers to cancel their subscriptions, according to people familiar with the matter as reported by Bloomberg on Thursday.

Since reports of the investigation, (NYSE: HIMS) stock dropped 2.6%.

The investigation has not resulted in any formal accusations of wrongdoing against the company.